1
|
Baig A, Gafoor-Haseeb S, Goldsher J, Siddique F. Updates in the Management of Giant Cell Arteritis. Curr Neurol Neurosci Rep 2024; 24:285-291. [PMID: 38913278 DOI: 10.1007/s11910-024-01348-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/10/2024] [Indexed: 06/25/2024]
Abstract
PURPOSE OF THE REVIEW To briefly review the latest updates in management in giant cell arteritis, an autoimmune vasculitis affecting the medium to large vessels. RECENT FINDINGS Here, we review the known and newer trends in management of giant cell arteritis. While high dose glucocorticoids remain the mainstay of therapy, immunosuppressive medications are increasingly utilized to reduce the burden and risk of long-term glucocorticoid use. Published guidelines by the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) suggest early use of steroid-sparing immunosuppressive medications in patients with recently diagnosed or relapsing giant cell arteritis. Immunosuppressive medications include oral small molecules such as methotrexate and leflunomide and biologics, including the recently Federal Drug Administration (FDA) approved tocilizumab. Glucocorticoids remain the cornerstone of management for newly diagnosed disease but with the increasing use of medications such as IL-6 inhibitors, patients are decreasing steroid use within weeks, thereby limiting risks associated with long-term steroid use.
Collapse
Affiliation(s)
- Aqil Baig
- St James School of Medicine, A-1, Albert Lake Dr, The Quarter, 2640, Anguilla
| | - Sana Gafoor-Haseeb
- Loyola University Medical Center, 2160 S First Ave, Maywood, IL, 60153, USA
| | - Jay Goldsher
- Internal Medicine Resident, Loyola University Medical Center, 2160 S First Ave, Maywood, IL, 60153, USA
| | - Faizah Siddique
- Loyola University Medical Center, 2160 S First Ave, Maywood, IL, 60153, USA.
| |
Collapse
|
2
|
Taroza S, Jatužis D, Matijošaitis V, Raugelė S, Valaikienė J. Central retinal artery occlusion or retinal stroke: a neurosonologist's perspective. Front Neurol 2024; 15:1397751. [PMID: 38915799 PMCID: PMC11194405 DOI: 10.3389/fneur.2024.1397751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2024] [Accepted: 05/22/2024] [Indexed: 06/26/2024] Open
Abstract
In central retinal artery occlusion (CRAO) or retinal stroke, which is usually a vision-threatening condition, timely diagnosis is imperative to improve the chances of retinal preservation and to establish adequate secondary prevention measures. Even though retinal strokes have been traditionally assigned to the field of ophthalmology, while considering reperfusion therapy as the only way to avoid permanent vision loss, we suggest prompt evaluation of CRAO causes (primarily related to cardiovascular risk factors) performed by a well-organized interdisciplinary team (ophthalmologist and neurologist) in a neurovascular center with stroke expertise. Therefore, the most suitable adjunct method for rapidly diagnosing non-arteritic CRAO could be target transorbital ultrasound, performed by an experienced neurologist/neurosonologist in the stroke unit. Consequently, after an ophthalmological assessment, a final decision on thrombolytic therapy could be made. We accept that further research is obviously needed to determine whether transorbital ultrasound could replace ophthalmological investigation in the case of a suspected acute retinal stroke. We assert that retinal stroke requires interdisciplinary treatment in cooperation with neurologists and ophthalmologists, with an additive value for each to achieve the best results for the patient.
Collapse
Affiliation(s)
- Saulius Taroza
- Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, Palanga, Lithuania
- Klaipėda University Hospital, Klaipėda, Lithuania
| | - Dalius Jatužis
- Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
| | - Vaidas Matijošaitis
- Department of Neurology, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Saulius Raugelė
- Klaipėda University Hospital, Klaipėda, Lithuania
- Faculty of Health Sciences, Klaipėda University, Klaipėda, Lithuania
| | - Jurgita Valaikienė
- Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
| |
Collapse
|
3
|
Correia PN, Meyer IA, Odier C. Intrinsic stenosing and occlusive pathologies of the vertebral artery: A narrative review. Neurochirurgie 2024; 70:101527. [PMID: 38295574 DOI: 10.1016/j.neuchi.2023.101527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Accepted: 12/19/2023] [Indexed: 02/02/2024]
Abstract
Intrinsic pathologies of the vertebral arteries, such as atherosclerosis, dissection, fibromuscular dysplasia, radionecrosis and vasculitis, are important causes of vertebrobasilar insufficiency and cerebrovascular events. This review focuses on non-aneurysmal intrinsic stenosing and occlusive pathologies, covering their epidemiology, diagnosis, and treatment options. It also provides a detailed summary of key clinical presentations and syndromes, including an in-depth examination of lateral medullary syndrome, historically known as Wallenberg's syndrome, which is arguably the most emblematic condition resulting from vertebral artery involvement and is depicted in an illustrative cartoon.
Collapse
Affiliation(s)
- Pamela N Correia
- Montreal Neurovascular Stroke Program, Department of Neurosciences, Université de Montréal, Montréal, QC, Canada; Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada; Stroke Unit, Department of Neurology, Bienne Hospital Centre, Bienne, Switzerland.
| | - Ivo A Meyer
- Neurology and Acute Neurorehabilitation Service, Department of Clinical Neurosciences, Lausanne University Hospital, Lausanne, Switzerland; Centre for Advanced Research in Sleep Medicine and Integrated Trauma Centre, CIUSSS du Nord-de-l'Île-de-Montréal, Montreal, QC, Canada
| | - Céline Odier
- Department of Medicine (Neurology), Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada; Department of Neurosciences, Université de Montréal, Montréal, QC, Canada; Neurovascular Group, Neurosciences Axis, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada
| |
Collapse
|
4
|
Finelli PF, Nouh AH. MR Restricted Diffusion in Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis. J Neuroophthalmol 2024; 44:e176-e177. [PMID: 37163351 DOI: 10.1097/wno.0000000000001853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Affiliation(s)
- Pasquale F Finelli
- Department of Neurology (PFF), Hartford Hospital and University of Connecticut School of Medicine, Hartford, Connecticut; and Cleveland Clinic Florida (AN), Department of Neurology, Cleveland Clinic Neurologic Institute, Weston, Florida
| | | |
Collapse
|
5
|
Shimura M, Fujikawa H, Suda M, Muranaka K, Minoda M. A Case of Visual Hallucination With Frontal Lobe Infarction in a Patient With Giant Cell Arteritis. Cureus 2023; 15:e41659. [PMID: 37575842 PMCID: PMC10412741 DOI: 10.7759/cureus.41659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/09/2023] [Indexed: 08/15/2023] Open
Abstract
Giant cell arteritis (GCA) can produce a variety of visual symptoms. Among these, visual hallucinations are rare and are usually accompanied by visual loss. We encountered a 79-year-old female with GCA who presented with visual hallucinations without visual loss. Magnetic resonance imaging (MRI) of the head revealed a stroke in the right frontal lobe, probably caused by GCA, resulting in visual hallucinations. Visual hallucinations are not well recognized by clinicians as a presentation of GCA. However, as shown in the present case, visual hallucinations are an important symptom because they are suggestive of cerebral ischemia or visual loss.
Collapse
Affiliation(s)
- Mai Shimura
- Department of Internal Medicine, Suwa Central Hospital, Nagano, JPN
- Department of Medical Oncology, National Cancer Center Hospital East, Chiba, JPN
| | - Hirohisa Fujikawa
- Center for General Medicine Education, School of Medicine, Keio University, Tokyo, JPN
- Department of Internal Medicine, Suwa Central Hospital, Nagano, JPN
| | - Masei Suda
- Department of Internal Medicine, Suwa Central Hospital, Nagano, JPN
| | | | - Masahiro Minoda
- Department of Internal Medicine, Suwa Central Hospital, Nagano, JPN
| |
Collapse
|
6
|
Dixon L, Colquhoun M, Taylor E, Carlucci F, Limback-Stanic C, Singh-Curry V, Tona F, Youngstein T. Orbital giant cell arteritis: two cases of bilateral orbital inflammation and arterial diffusion restriction on MRI. J Neurol 2023; 270:2793-2797. [PMID: 36774429 DOI: 10.1007/s00415-023-11593-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Revised: 01/26/2023] [Accepted: 01/27/2023] [Indexed: 02/12/2023]
Affiliation(s)
- Luke Dixon
- Neuroradiology, Department of Imaging, Imperial College NHS Healthcare Trust, London, UK.
| | - Matthew Colquhoun
- Department of Rheumatology, Imperial College NHS Healthcare Trust, London, UK
| | - Eleanor Taylor
- Neuroradiology, Department of Imaging, Imperial College NHS Healthcare Trust, London, UK
| | - Francesco Carlucci
- Department of Rheumatology, Imperial College NHS Healthcare Trust, London, UK
| | - Clara Limback-Stanic
- Department of Neuropathology and Ocular Pathology, Oxford University Hospital NHS Foundation Trust, London, UK
| | | | - Francesca Tona
- Neuroradiology, Department of Imaging, Imperial College NHS Healthcare Trust, London, UK
| | - Taryn Youngstein
- Department of Rheumatology, Imperial College NHS Healthcare Trust, London, UK
| |
Collapse
|
7
|
Issa M, Donaldson L, Jeeva-Patel T, Margolin E. Ischemic ocular manifestations of giant cell arteritis: A Canadian case series. J Neurol Sci 2022; 436:120222. [DOI: 10.1016/j.jns.2022.120222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2022] [Revised: 02/28/2022] [Accepted: 03/03/2022] [Indexed: 10/18/2022]
|
8
|
Abstract
The many forms of vasculitis are characterized by inflammation of blood vessels, leading to potentially long-term sequelae including vision loss, aneurysm formation and kidney failure. Accurate estimation of the incidence and prevalence has been hampered by the absence of reliable diagnostic criteria and the rarity of these conditions; however, much progress has been made over the past two decades, although data are still lacking from many parts of the world including the Indian subcontinent, China, Africa and South America. Giant cell arteritis occurs in those aged 50 years and over and seems to mainly affect persons of northern European ancestry, whereas Takayasu arteritis occurs mainly in those aged under 40 years. By contrast, Kawasaki disease mainly occurs in children aged under 5 years and is most common in children of Asian ancestry, and IgA vasculitis occurs in children and adolescents. Although much less common than giant cell arteritis, the different forms of antineutrophil cytoplasmic antibody-associated vasculitis are being increasingly recognized in most populations and occur more frequently with increasing age. Behçet syndrome occurs most commonly along the ancient silk road between Europe and China. Much work needs to be done to better understand the influence of ethnicity, geographical location, environment and social factors on the development of vasculitis.
Collapse
|
9
|
Zhou L, Wei X. Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer. Front Immunol 2021; 12:701951. [PMID: 34504488 PMCID: PMC8421677 DOI: 10.3389/fimmu.2021.701951] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Accepted: 08/05/2021] [Indexed: 02/05/2023] Open
Abstract
Immune checkpoint inhibitors (ICIs) are novel immunotherapy-based drugs that have become increasingly popular in the treatment of lung cancer. Researchers have recognized ocular immune-related adverse events (irAEs) secondary to ICIs because of their vision-threatening characteristics. However, they are incompletely characterized and no studies have reported the ICI-related ocular irAEs in lung cancer. Therefore, we aimed to comprehensively illustrate the clinical characteristics, contributory factors, diagnosis, and management of ICI-related ocular irAEs in lung cancer, based on previously reported 79 patients. Ophthalmoplegia (40.51%), uveitis (20.25%), and dry eye (17.72%) were the most common ICI-related ocular irAEs in lung cancer. Ptosis was the most common (36.71%) and the highest mortality (23.33%) of ophthalmoplegia. Patients in Asia and patients who underwent combination therapy with programmed cell death-1 and cytotoxic T-lymphocyte-associated antigen 4 inhibitors demonstrated significantly higher frequency of ophthalmoplegia than other ocular irAEs. Most ICI-related ophthalmoplegia and uveitis in lung cancer were observed in the first 10 weeks following the initiation of ICIs. Furthermore, the onset time of dry eye and other ocular irAEs was much longer. In addition, 92.31% of the patients with ocular irAEs other than ophthalmoplegia could be remised. In conclusion, ocular irAEs secondary to ICIs in lung cancer are non-negligible, particularly ophthalmoplegia. Ethnicity and the type of ICIs play important roles in the distribution of ocular irAEs. ICI-related ophthalmoplegia in lung cancer presented with early onset and worse prognosis features, thus necessitating further attention.
Collapse
Affiliation(s)
- Lin Zhou
- Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China
| | - Xin Wei
- Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China
| |
Collapse
|